Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 4 EP applications Stephen Phillip McNeeney has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 30, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12775283

NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE

IPC classification:
A61K 31/485, A61K 9/20, A61K 9/14, A61K 9/00
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
PATENT GRANTED
EP12703125

NOVEL FORMULATIONS FOR DERMAL, TRANSDERMAL AND MUCOSAL USE 1

IPC classification:
A61K 9/70, A61K 47/14, A61K 47/10, A61K 47/06, A61K 9/00
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12703537

NOVEL ANTIFUNGAL COMPOSITION

IPC classification:
A61K 31/137, A61K 47/12, A61K 47/10, A61K 31/00, A61K 9/00, A61K 47/18, A61K 31/13
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14725742

A SOLID NANOPARTICLE WITH INORGANIC COATING

IPC classification:
A61K 9/51, A61K 9/50
Agent:
Stephen Phillip McNeeney, Potter Clarkson LLP
Agent:
Brann AB
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature